What they were paid
Protalix BioTherapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $45,000 | $0 | $26,341 | $0 | $71,341 |
| FY2024 | $33,750 | $0 | $0 | $0 | $33,750 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protalix BioTherapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001104659-26-053016, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation · Nominating/Governance
The rest of the Protalix BioTherapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Aharon Schwartz, Ph.D | Independent Director | $71,708 |
| Amos Bar Shalev | Independent Director | $71,708 |
| Christian Elze | Director | $20,076 |
| Dror Bashan | Director | $0 |
| Eliot Richard Forster, Ph.D | Independent Director | $99,575 |
| Gwen A. Melincoff | Independent Director | $71,708 |
| Pol F. Boudes, M.D | Independent Director | $71,708 |
The full Protalix BioTherapeutics compensation record
free company briefThis page is one director within Protalix BioTherapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat